Inhibition of transcription factors with small organic molecules.

[1]  T. Berg.  Signal Transducers and Activators of Transcription as Targets for Small Organic Molecules , 2008, Chembiochem : a European journal of chemical biology.

[2]  Judith M. Müller,et al.  Discovery of Chromone‐Based Inhibitors of the Transcription Factor STAT5 , 2008, Chembiochem : a European journal of chemical biology.

[3]  D. Boger,et al.  Disruption of the MYC transcriptional function by a small-molecule antagonist of MYC/MAX dimerization. , 2008, Oncology reports.

[4]  William P. Katt,et al.  An oxazole-based small-molecule Stat3 inhibitor modulates Stat3 stability and processing and induces antitumor cell effects. , 2007, ACS chemical biology.

[5]  Dirk Eick,et al.  Transcribing RNA Polymerase II Is Phosphorylated at CTD Residue Serine-7 , 2007, Science.

[6]  Christopher L. McClendon,et al.  Reaching for high-hanging fruit in drug discovery at protein–protein interfaces , 2007, Nature.

[7]  M. Raes,et al.  Dual effect of echinomycin on hypoxia‐inducible factor‐1 activity under normoxic and hypoxic conditions , 2007, The FEBS journal.

[8]  G. Semenza,et al.  Hypoxia-Inducible Factor 1 (HIF-1) Pathway , 2007, Science's STKE.

[9]  G. Semenza.  Evaluation of HIF-1 inhibitors as anticancer agents. , 2007, Drug discovery today.

[10]  R. Kornberg,et al.  The molecular basis of eukaryotic transcription (Nobel Lecture). , 2007, Angewandte Chemie.

[11]  P. Dervan,et al.  Modulating hypoxia-inducible transcription by disrupting the HIF-1-DNA interface. , 2007, ACS chemical biology.

[12]  A. Mapp,et al.  Disrupting Mediator with a Short Peptide Ligand , 2007, Chembiochem : a European journal of chemical biology.

[13]  Bianca Sperl,et al.  Selective Inhibition of c‐Myc/Max Dimerization by a Pyrazolo[1,5‐a]pyrimidine , 2007, ChemMedChem.

[14]  W. Guida,et al.  Selective chemical probe inhibitor of Stat3, identified through structure-based virtual screening, induces antitumor activity , 2007, Proceedings of the National Academy of Sciences.

[15]  J. McMurray,et al.  Solid-phase synthesis of Stat3 inhibitors incorporating O-carbamoylserine and O-carbamoylthreonine as glutamine mimics. , 2007, Bioorganic & medicinal chemistry letters.

[16]  John P. Overington,et al.  How many drug targets are there? , 2006, Nature Reviews Drug Discovery.

[17]  Bianca Sperl,et al.  Stattic: a small-molecule inhibitor of STAT3 activation and dimerization. , 2006, Chemistry & biology.

[18]  P. Imming,et al.  Drugs, their targets and the nature and number of drug targets , 2006, Nature Reviews Drug Discovery.

[19]  M. Henriksson,et al.  Myc Overexpression Enhances Apoptosis Induced by Small Molecules , 2006, Cell cycle.

[20]  D. Felsher,et al.  Tumor Dormancy: Death and Resurrection of Cancer As Seen through Transgenic Mouse Models , 2006, Cell cycle.

[21]  B. Groner,et al.  The Biological Functions of the Versatile Transcription Factors STAT3 and STAT5 and New Strategies for their Targeted Inhibition , 2006, Journal of Mammary Gland Biology and Neoplasia.

[22]  M. Cole,et al.  Mechanism of transcriptional activation by the Myc oncoproteins. , 2006, Seminars in cancer biology.

[23]  Kathryn A. O’Donnell,et al.  The c-Myc target gene network. , 2006, Seminars in cancer biology.

[24]  M. Henriksson,et al.  The Myc oncoprotein as a therapeutic target for human cancer. , 2006, Seminars in cancer biology.

[25]  P. Dervan,et al.  Programmable oligomers for minor groove DNA recognition. , 2006, Journal of the American Chemical Society.

[26]  R. Shoemaker,et al.  Targeting the PAS-A Domain of HIF-1α for Development of Small Molecule Inhibitors of HIF-1 , 2006, Cell cycle.

[27]  Hans‐Dieter Arndt.  Small molecule modulators of transcription. , 2006, Angewandte Chemie.

[28]  Dirk Eick,et al.  Selective inhibition of c-Myc/Max dimerization and DNA binding by small molecules. , 2006, Chemistry & biology.

[29]  A. Chapman-Smith,et al.  Novel DNA Binding by a Basic Helix-Loop-Helix Protein , 2006, Journal of Biological Chemistry.

[30]  M. Henriksson,et al.  Identification of small molecules that induce apoptosis in a Myc-dependent manner and inhibit Myc-driven transformation. , 2006, Proceedings of the National Academy of Sciences of the United States of America.

[31]  P. Vogt,et al.  A credit-card library approach for disrupting protein-protein interactions. , 2006, Bioorganic & medicinal chemistry.

[32]  J. Grandis,et al.  STAT3 as a therapeutic target in head and neck cancer , 2006, Expert opinion on biological therapy.

[33]  Chinmay Y. Majmudar,et al.  Chemical approaches to transcriptional regulation. , 2005, Current opinion in chemical biology.

[34]  A. Monks,et al.  Echinomycin, a small-molecule inhibitor of hypoxia-inducible factor-1 DNA-binding activity. , 2005, Cancer research.

[35]  M. Eilers,et al.  Transcriptional regulation and transformation by Myc proteins , 2005, Nature Reviews Molecular Cell Biology.

[36]  J. Darnell,et al.  Validating Stat3 in cancer therapy , 2005, Nature Medicine.

[37]  D. Scudiero,et al.  A high-throughput fluorescence-anisotropy screen that identifies small molecule inhibitors of the DNA binding of B-ZIP transcription factors. , 2005, Analytical biochemistry.

[38]  Renxiao Wang,et al.  A low-molecular-weight compound discovered through virtual database screening inhibits Stat3 function in breast cancer cells. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[39]  J. Klco,et al.  Inhibition of vascular endothelial growth factor with a sequence-specific hypoxia response element antagonist. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[40]  J. Turkson,et al.  Novel peptidomimetic inhibitors of signal transducer and activator of transcription 3 dimerization and biological activity. , 2004, Molecular cancer therapeutics.

[41]  John S Lazo,et al.  Low molecular weight inhibitors of Myc–Max interaction and function , 2003, Oncogene.

[42]  Stephen K. Burley,et al.  X-Ray Structures of Myc-Max and Mad-Max Recognizing DNA Molecular Bases of Regulation by Proto-Oncogenic Transcription Factors , 2003, Cell.

[43]  A. Hopkins,et al.  The druggable genome , 2002, Nature Reviews Drug Discovery.

[44]  D. Boger,et al.  Small-molecule antagonists of Myc/Max dimerization inhibit Myc-induced transformation of chicken embryo fibroblasts , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[45]  W. Delano.  The PyMOL Molecular Graphics System , 2002 .

[46]  J. Turkson,et al.  Phosphotyrosyl Peptides Block Stat3-mediated DNA Binding Activity, Gene Regulation, and Cell Transformation* , 2001, The Journal of Biological Chemistry.

[47]  B. Kräutler,et al.  Structure, function, and dynamics of the dimerization and DNA-binding domain of oncogenic transcription factor v-Myc. , 2001, Journal of molecular biology.

[48]  S. Becker,et al.  Three-dimensional structure of the Stat3β homodimer bound to DNA , 1998, Nature.

[49]  W. DeGrado,et al.  DNA-induced increase in the alpha-helical content of C/EBP and GCN4. , 1991, Biochemistry.